UK and Ireland ITP Support Association Convention 2021
Dr David Kuter
Dr. David Kuter is Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. He received his undergraduate degree from Harvard College and his D. Phil. in Biochemistry while a Rhodes Scholar at Oxford University, before obtaining his medical degree from Harvard Medical School. Dr. Kuter divides his time between medical education of fellows and medical students, clinical care of patients with a wide range of hematological disorders, and clinical research of thrombopoietic agents. His basic science group was one of the labs that discovered thrombopoietin and his clinical research group carried out seminal studies using thrombopoietic agents in transfusion medicine and immune thrombocytopenia (ITP).
Dr Nichola Cooper
Dr Nichola Cooper trained at Cambridge University and Barts and the London School of Medicine and Dentistry. She completed her haematology training at University College Hospital and subsequently gained research experience at Cornel Medical College, New York and the Institute of Child Health, University College London.
Dr Cooper has an expertise in Immunohaematology, autoimmune diseases, thrombocytopenia, immune thrombocytopenia (ITP) and runs a clinical and laboratory research group focusing on immune haematology, in particular immune thrombocytopenia (ITP).
Dr Drew Provan
Dr Drew Provan is currently Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. Dr. Provan studied molecular genetics at Leicester University before studying medicine. After junior medical posts in the UK, he undertook research at The Dana-Farber Cancer Institute from 1993-4 on an American Traveling fellowship awarded by the Medical Research Council.
Dr. Provan took up the post of Consultant Haematologist in Southampton in 1995 and moved to Barts and The London in 2000. As a general haematologist, his main area of interest within the field of haematology is immunohaematology which includes diseases such as autoimmune thrombocytopenia (ITP), neutropenia and haemolytic anaemia. Dr. Provan has established the UK ITP Registry (www.ukitpregistry.com) a clinical and laboratory database of patients with ITP. This facilitates the collection of clinical information related to adults with ITP throughout the UK, Europe and other countries, in addition to allowing for DNA samples to be obtained for genetic analysis, in an attempt to determine the underlying mechanisms leading to autoantibody production. This database is a potential tool for identifying surrogate markers of likely clinical outcomes and may allow for the identification of treatment response genes. Examining gene expression profiles in patients with ITP at various stages in the disease history, might allow for the identification of causal genes that may be over or under-expressed in patients with ITP.
Dr Provan, along with International colleagues published the consensus guidelines for the diagnosis and management of ITP in children and adults published in Blood.
Dr John Grainger
Dr Grainger is Chair of British Society of Haematology Paediatric Haematology committee, national lead for paediatric ITP, national lead for IVIg in haematology and national lead for paediatric haematology training.
He has a special interest in Bleeding disorders and thrombosis, Immune Thrombocytopenic Purpura (ITP), haemoglobinopathy, childhood leukaemia and haematology training.
He is the local lead for haemophilia, haemoglobinopathy and non-malignant haematology, and for early phase clinical trials. He is also the medical advisor for the ITP Support Association.
Dr Sue Pavord
Dr Sue Pavord is a Consultant Haematologist at Oxford University Hospitals and Associate Senior Lecturer in Medicine at St Edmund Hall. She qualified from the University of Leicester in 1988 and in her early career, spent time at McMaster University, Canada, researching Immune haematology. She has over 25 years’ experience in clinical and laboratory haematology.
Her specialist areas of interest are anaemia and iron management, immune haematology, inherited and acquired bleeding disorders, thrombosis and anticoagulation, thrombosis prevention and obstetric haematology.
Dr Cindy Neunert
Dr Cindy Neunert is an Associate Professor of Paediatrics at Columbia University at CUMC, New York and an Attending Physician Paediatrics at New York Presbyterian Morgan Stanley Children’s Hospital, New York. She joined our medical advisers in 2016 and has enjoyed a long-standing relationship with Professor James George of Oklahoma and George Buchanan from Dallas, Texas. Dr Neunert Dr. also contributes to the ITP Support Associations Platelet Journal with the 'Letter from America' column.
Dr Susan Robinson
Dr Susan Robinson became a consultant at Guy's and St Thomas' NHS Foundation Trust in 2010 and is also the co-clinical director with Claire Harrison. She is the lead clinician for patient blood management, pre-operative and post-operative correction of anaemia, transfusion medicine, immune thrombocytopenia, and obstetric haematology (anaemia, thrombocytopenia, thrombosis, antiphospholipid syndrome, myeloproliferative neoplasms in pregnancy).
Susan Chairs the British Society for Haematology Transfusion Task Force and is a writing group member of the National Institute for Health and Care Excellence transfusion guidelines, specialist committee member NICE quality standards for transfusion and Serious Hazards of Transfusion (SHOT) working group expert.
Prof Adrian Newland
Adrian Newland is Professor of Haematology at Barts Health National Health Service (NHS) Trust, London, UK. He has a research department within the Medical School, where he is a former Head of the Division of Haematology, Oncology and Imaging. Professor Newland has a particular interest in novel treatments and support therapy, and is involved in guideline development and a multidisciplinary approach to patient care. His clinical interests are in immune haematology and he jointly developed the National Registry for Immune Thrombocytopenia to collect comprehensive epidemiological and clinical data. Professor Newland’s group undertakes research into the molecular and immune basis of autoimmune disease and he has an active clinical research programme in novel treatments. He helped develop the ITP Clinical Network in the UK as a basis for clinical studies. Professor Newland co-chairs the WHO Strategic Advisory Group of experts on in-vitro diagnostics, is clinical advisor for pathology to NHS England and was President of the Royal College of Pathologists from 2005–2008 and the International Society of Hematology (ISH) from 2014–2016. Professor Newland is Senior Editor of Hematology, the journal of the ISH, and he has published over 300 peer-reviewed papers in international journals. Prof Newland is also the Chair of Trustees of the ITP Support Association.
Dr Vickie McDonald
Dr Vickie McDonald is a consultant haematologist with a specialist interest in coagulation and platelet disorders at the Royal London Hospital. She completed her haematology training at Guys and St Thomas’ NHS Foundation Trust and a PhD at University College London, following which she became a consultant in haemostasis and thrombosis at Guys and St Thomas’ NHS Foundation Trust in 2012. In 2017 she moved to the Royal London Hospital working with patients with inherited and acquired coagulation disorders but also taking the national lead for the UK ITP registry. She runs specialist clinics in ITP and is actively involved in several clinical trials in ITP, both early and late phase studies.
Dr Catherine Bagot
Catherine Bagot graduated MBBS from St Mary’s Hospital Medical School, London in 1995, having also undertaken an Intercalated BSc in the History of Medicine at University College London (second class, upper division) awarded in 1992. After initially pursuing a career in Obstetrics and Gynaecology, she undertook an MD at Yale University Medical School in New Haven, USA, investigating the role of maternal HOXA10 expression in embryonic implantation. The MD was awarded by the University of London in 2002. On her return, she trained in general medicine obtaining MRCP in 2002 and then undertook specialist training in haematology in the South East London Deanery obtaining FRCPath in 2007. During her specialist training in haematology, she undertook a 2 year period of full time research investigating the effect of hormone replacement therapy on thrombin generation, a global assay of coagulation.
Dr Bagot has been a consultant haematologist at Glasgow Royal Infirmary since 2010. She specialises in haemostasis and thrombosis and is the co-lead for Haematology Obstetric services in North Glasgow. Dr Bagot is also a principal investigator in a number of national and international trials investigating new treatments for ITP and haemophilia.
Prof John Semple
John W. Semple is currently a Professor of Transfusion Medicine in the Division of Hematology and Transfusion Medicine at Lund University. His research interests are aimed at the pathogenesis of immune thrombocytopenia (ITP), platelets as immune cells and the induction and pathogenesis of transfusion related acute lung injury (TRALI).
Dr Adam Cuker
Dr. Adam Cuker is a hematologist in Philadelphia, Pennsylvania and is affiliated with multiple hospitals in the area, including Pennsylvania Hospital and Hospitals of the University of Pennsylvania-Penn Presbyterian. He received his medical degree from Yale University School of Medicine and has been in practice between 11-20 years. Dr. Cuker also contributes to the ITP Support Associations Platelet Journal with the 'Letter from America' column.
Dr Kate Khair
Dr Kate Khair is a state registered nurse with a number of other professional qualifications including state registration in paediatric nursing, a master’s degree in anthropology, a City and Guilds master’s degree in higher levels of practice, several modules in advanced nursing and a PhD in health and social care.
Kate is an advocate of the nurse’s role in the multi-disciplinary team, and uses her academic time to continue her work into lived experience research in bleeding disorders as well as to support PhD students in health outcomes research.
Dr Quentin Hill
Dr Quentin Hill is a Consultant Haematologist at Leeds Teaching Hospitals and an Honorary Clinical Associate Professor at the University of Leeds. His areas of specialist interest include red cell disorders and immune haematology. Dr Hill is also the Chair of the UK ITP Forum and will shortly be joining the board of the ITP Support Association as an ex officio member.